Today: 11 June 2026
Gold price today: $5,000 in sight as bullion hits another record ahead of Fed week
23 January 2026
2 mins read

Gold price today: $5,000 in sight as bullion hits another record ahead of Fed week

New York, January 23, 2026, 17:03 EST — After-hours.

  • Gold edges to fresh highs, staying just shy of $5,000
  • Dollar and yields ease as traders brace for the Fed meeting next week
  • Physical premiums jump in India even as local prices set records

Gold prices hovered just below the $5,000 mark on Friday after touching a fresh record, keeping the metal in the spotlight at the end of a volatile week. Spot gold was up 0.6% at $4,964.81 an ounce after hitting $4,988.17, while U.S. gold futures for February delivery settled 1.4% higher at $4,979.70. “Gold’s role as a haven and a diversifier in highly uncertain economic and political times is making it a necessity for strategic portfolios,” said Tai Wong, an independent metals trader. Investing.com

The gold price move tracked a broad dip in the dollar and softer U.S. Treasury yields, a mix that tends to help bullion because it pays no interest. The dollar index — a measure of the greenback against a basket of major currencies — fell 0.61% to 97.70, while traders put the odds of the Fed holding rates steady next week at 97% via futures pricing.

A day earlier, gold pushed past $4,900 for the first time, powered by geopolitical tensions, a softer dollar and expectations the Federal Reserve will cut rates later this year. The latest U.S. Personal Consumption Expenditures (PCE) report, the Fed’s preferred inflation gauge, came in line with expectations, while markets continued to price two quarter-point cuts in the second half of the year. “Geopolitical tensions, generally weak dollar, expectations for the Fed easing this year are all factors… still impacting the demand,” said Peter Grant, vice president and senior metals strategist at Zaner Metals. Reuters

The rally has pulled the rest of the precious metals complex along. Silver vaulted above $100 an ounce, with StoneX analyst Rhona O’Connell calling it “a self-propelled frenzy,” while BNP Paribas strategist David Wilson warned profit-taking could arrive “sooner rather than later” after the pace of gains since late November. Reuters

In physical markets, premiums in top consumer India jumped this week to the highest in more than a decade as buyers positioned for a possible import duty hike in the February 1 budget. Dealers charged a premium of up to $112 an ounce over official domestic prices, while local prices hit a record 159,226 rupees per 10 grams; “Demand was really strong this week and ran ahead of supply,” said Chanda Venkatesh, managing director of bullion merchant CapsGold. Reuters

Banks are also leaning into the move. Goldman Sachs raised its end-2026 gold price forecast to $5,400 an ounce from $4,900, citing private-sector diversification buying and emerging-market central banks’ demand, while flagging a pullback risk if policy fears fade and investors unwind hedges.

On the macro front, U.S. business activity was steady in January while price pressures remained elevated, with firms citing import tariffs as a key driver, according to S&P Global’s flash PMI surveys. “Increased costs, widely blamed on tariffs, are again cited as a key driver of higher prices,” said Chris Williamson, chief business economist at S&P Global Market Intelligence, as investors looked to next week’s Fed decision for guidance. Reuters

But the pace itself is a risk. After a fast run toward a big round number, gold can slip on a rebound in the dollar, a jump in yields, or any hint from the Fed that it plans to keep policy tight for longer than traders expect.

Next up is the Federal Reserve’s January 27–28 meeting, with the statement and a press conference on January 28 likely to set the tone for rate expectations, the dollar and the next leg in gold.

Stock Market Today

  • Kymera Therapeutics Stock Rebounds Amid Valuation Debate at $78.23
    June 10, 2026, 10:45 PM EDT. Kymera Therapeutics (KYMR) shares rose 6.9% last week after a 7% decline over the past month, trading at $78.23 with a 33.9% undervaluation consensus. Analyst fair value estimates average $118.27, implying substantial upside based on planned annual IND (Investigational New Drug) filings and a cash runway into mid-2027 supporting R&D. The biotech's long-term shareholders have seen a 1-year total return of 61.7% and 3-year return above 200%. Risks remain from potential R&D setbacks and partner dependency, notably on Sanofi, tempering the growth outlook. Investors are advised to closely evaluate positive catalysts alongside the execution challenges in this AI-driven drug development sector.

Latest articles

Tech stocks slide after hours, Oracle’s AI spending draws focus

Tech stocks slide after hours, Oracle’s AI spending draws focus

11 June 2026
Semiconductor stocks plunged 3.6%, dragging the S&P 500 technology sector into correction territory—down 11% from its June 2 record—as investors punished AI-linked companies like Oracle and Super Micro Computer for heavy spending and capital raises, signaling a shift in risk appetite amid rising inflation and escalating U.S.-Iran tensions.
Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

11 June 2026
Murphy USA soared 10.04% to $612.16 as investors seized on Casey’s General Stores’ stronger-than-expected fuel margins, spotlighting sector-wide pump profitability; with Murphy’s own first-quarter fuel contribution up 40.6% and margins at 35.0 cents per gallon, the stock’s jump reflects bets that high margins will persist, though volatility in fuel prices remains a key risk.
Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

11 June 2026
Sky Quarry soared 22.44% to $1.91 on record volume, then jumped to $2.38 after hours, as investors bet on a June refinery restart after repairs and a feedstock shortage crushed Q1 revenue to $383; with just $66,828 in cash and “substantial doubt” about its ability to continue, the stock’s fate hinges on hitting its June production target.
Apple stock slips as China discounts and memory-chip costs sharpen focus on next week’s earnings
Previous Story

Apple stock slips as China discounts and memory-chip costs sharpen focus on next week’s earnings

Oracle stock slips after Morgan Stanley warning; TikTok U.S. deal puts ORCL in play
Next Story

Oracle stock slips after Morgan Stanley warning; TikTok U.S. deal puts ORCL in play

Go toTop